- Home
- VCTR vs ADMA Comparison
VCTR vs ADMA Comparison
Compare VCTR & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCTR
- ADMA
- Stock Information
- Founded
- VCTR 2013
- ADMA 2004
- Country
- VCTR United States
- ADMA United States
- Employees
- VCTR N/A
- ADMA N/A
- Industry
- VCTR Investment Managers
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VCTR Finance
- ADMA Health Care
- Exchange
- VCTR Nasdaq
- ADMA Nasdaq
- Market Cap
- VCTR 4.4B
- ADMA 5.1B
- IPO Year
- VCTR 2018
- ADMA N/A
- Fundamental
- Price
- VCTR $62.16
- ADMA $17.74
- Analyst Decision
- VCTR Buy
- ADMA Strong Buy
- Analyst Count
- VCTR 10
- ADMA 4
- Target Price
- VCTR $70.80
- ADMA $24.25
- AVG Volume (30 Days)
- VCTR 288.1K
- ADMA 2.7M
- Earning Date
- VCTR 08-07-2025
- ADMA 08-07-2025
- Dividend Yield
- VCTR 2.90%
- ADMA N/A
- EPS Growth
- VCTR 38.50
- ADMA N/A
- EPS
- VCTR 4.50
- ADMA 0.84
- Revenue
- VCTR $897,222,000.00
- ADMA $459,381,000.00
- Revenue This Year
- VCTR $42.70
- ADMA $23.35
- Revenue Next Year
- VCTR $15.14
- ADMA $27.67
- P/E Ratio
- VCTR $13.86
- ADMA $21.27
- Revenue Growth
- VCTR 7.38
- ADMA 62.23
- 52 Week Low
- VCTR $43.82
- ADMA $10.21
- 52 Week High
- VCTR $73.42
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- VCTR 50.33
- ADMA 32.83
- Support Level
- VCTR $60.97
- ADMA $20.42
- Resistance Level
- VCTR $63.42
- ADMA $22.37
- Average True Range (ATR)
- VCTR 1.58
- ADMA 0.88
- MACD
- VCTR -0.25
- ADMA -0.28
- Stochastic Oscillator
- VCTR 30.43
- ADMA 1.07
About VCTR Victory Capital Holdings Inc.
Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.